$PAB 0.032 Volume alertDecent whack of volume coming thru the last few days, strength in the Bg, A break n hold thru 34 is key here.
Pnf D target 0.082
−0.002 AUD
−3.54 M AUD
0.00 AUD
2.04 B
About PATRYS LIMITED
Sector
CEO
James A. Campbell
Headquarters
South Melbourne
Website
Founded
2006
ISIN
AU000000PAB9
FIGI
BBG000RHVFN9
Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. Its pipeline includes PAT-DX1 antibody fragment, PAT-DX3 full sized antibody, and PAT-DX1-NP conjugated to nanoparticles. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.
$PAB next stop 0.021 resistanceCheap MC, Patent secured today, volume in with buyers stepping up. Re-rating. BIOSHARE mentioned that PAB could be takeover before clinical trials due to interest in this technology. As always DYOR
PAB on the back of patent grant.PAB is looking strong with a patent being granted for its PAT-DX1 and PAT-DX3 use on cancer. If it is able to close above 1.8c today, watch for quick movement to 2.2c
$PAB - Patrys oversold.Going to take a punt on PAB for a monthly competition.
Buyer be very beware. Reasons on chart.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PAB is 0.004 AUD — it hasn't changed in the past 24 hours. Watch PATRYS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PATRYS LIMITED stocks are traded under the ticker PAB.
PAB stock hasn't changed in a week, the last month showed zero change in price, over the last year PATRYS LIMITED has showed a −50.00% decrease.
PAB stock is 33.33% volatile and has beta coefficient of 0.37. Track PATRYS LIMITED stock price on the chart and check out the list of the most volatile stocks — is PATRYS LIMITED there?
Yes, you can track PATRYS LIMITED financials in yearly and quarterly reports right on TradingView.
PAB net income for the last half-year is −1.59 M AUD, while the previous report showed −1.95 M AUD of net income which accounts for 18.69% change. Track more PATRYS LIMITED financial stats to get the full picture.
No, PAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PATRYS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PATRYS LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PATRYS LIMITED stock shows the sell signal. See more of PATRYS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.